Skip Header

1 - 25 of 75 results for author:"Kelsey K." in Literature citations

Page of 3 | Next »

to top of page·  

Results Customize

› Repeat search in UniProtKB (3)

Genetic associations of surfactant protein D and angiotensin-converting enzyme with lung disease in preterm neonates.

Ryckman K.K., Dagle J.M., Kelsey K., Momany A.M., Murray J.C.

J Perinatol 32:349-355(2012) · Mapped (1)

The relationship between tumor MSLN methylation and serum mesothelin (SMRP) in mesothelioma.

Nelson H.H., Almquist L.M., LaRocca J.L., Plaza S.L., Lambert-Messerlian G.M., Sugarbaker D.J., Bueno R., Godleski J.J., Marsit C.J., Christensen B.C. et al.

Epigenetics 6:1029-1034(2011) · Mapped (1)

LINE-1 hypomethylation is associated with bladder cancer risk among nonsmoking Chinese.

Cash H.L., Tao L., Yuan J.M., Marsit C.J., Houseman E.A., Xiang Y.B., Gao Y.T., Nelson H.H., Kelsey K.T.

Int. J. Cancer 130:1151-1159(2012) · Mapped (1)

DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression.

Zheng S., Houseman E.A., Morrison Z., Wrensch M.R., Patoka J.S., Ramos C., Haas-Kogan D.A., McBride S., Marsit C.J., Christensen B.C. et al.

Neuro-oncology 13:280-289(2011) · Mapped (11)

DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma.

Christensen B.C., Smith A.A., Zheng S., Koestler D.C., Houseman E.A., Marsit C.J., Wiemels J.L., Nelson H.H., Karagas M.R., Wrensch M.R. et al.

J. Natl. Cancer Inst. 103:143-153(2011) · Mapped (9)

Fine mapping of chromosome 15q25.1 lung cancer susceptibility in African-Americans.

Hansen H.M., Xiao Y., Rice T., Bracci P.M., Wrensch M.R., Sison J.D., Chang J.S., Smirnov I.V., Patoka J., Seldin M.F. et al.

Hum. Mol. Genet. 19:3652-3661(2010) · Mapped (18)

Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium.

Truong T., Hung R.J., Amos C.I., Wu X., Bickeboller H., Rosenberger A., Sauter W., Illig T., Wichmann H.E., Risch A. et al.

J. Natl. Cancer Inst. 102:959-971(2010) · Mapped (5)

KRAS mutation, KRAS-LCS6 polymorphism, and non-small cell lung cancer.

Nelson H.H., Christensen B.C., Plaza S.L., Wiencke J.K., Marsit C.J., Kelsey K.T.

Lung Cancer 69:51-53(2010) · Mapped (7)

Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer.

International Consortium of Bladder Cancer
Stern M.C., Lin J., Figueroa J.D., Kelsey K.T., Kiltie A.E., Yuan J.M., Matullo G., Fletcher T., Benhamou S., Taylor J.A. et al.

Cancer Res. 69:6857-6864(2009) · Mapped (18)

Genetic variation in CYP17A1 and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California.

Duell E.J., Holly E.A., Kelsey K.T., Bracci P.M.

Int. J. Cancer 126:790-795(2010) · Mapped (5)

DNA repair genotype interacts with arsenic exposure to increase bladder cancer risk.

Andrew A.S., Mason R.A., Kelsey K.T., Schned A.R., Marsit C.J., Nelson H.H., Karagas M.R.

Toxicol. Lett. 187:10-14(2009) · Mapped (6)

A let-7 microRNA-binding site polymorphism in the KRAS 3' UTR is associated with reduced survival in oral cancers.

Christensen B.C., Moyer B.J., Avissar M., Ouellet L.G., Plaza S.L., McClean M.D., Marsit C.J., Kelsey K.T.

Carcinogenesis 30:1003-1007(2009) · Mapped (7)

EGFR pathway polymorphisms and bladder cancer susceptibility and prognosis.

Mason R.A., Morlock E.V., Karagas M.R., Kelsey K.T., Marsit C.J., Schned A.R., Andrew A.S.

Carcinogenesis 30:1155-1160(2009) · Mapped (19)

Genetic variation in the vitamin C transporter, SLC23A2, modifies the risk of HPV16-associated head and neck cancer.

Chen A.A., Marsit C.J., Christensen B.C., Houseman E.A., McClean M.D., Smith J.F., Bryan J.T., Posner M.R., Nelson H.H., Kelsey K.T.

Carcinogenesis 30:977-981(2009) · Mapped (6)

Determination of genetic predisposition to patent ductus arteriosus in preterm infants.

Dagle J.M., Lepp N.T., Cooper M.E., Schaa K.L., Kelsey K.J., Orr K.L., Caprau D., Zimmerman C.R., Steffen K.M., Johnson K.J. et al.

Pediatrics 123:1116-1123(2009) · Mapped (1,774)

CYP1A1/2 haplotypes and lung cancer and assessment of confounding by population stratification.

Aldrich M.C., Selvin S., Hansen H.M., Barcellos L.F., Wrensch M.R., Sison J.D., Kelsey K.T., Buffler P.A., Quesenberry C.P. Jr., Seldin M.F. et al.

Cancer Res. 69:2340-2348(2009) · Mapped (12)

Bladder cancer SNP panel predicts susceptibility and survival.

Andrew A.S., Gui J., Sanderson A.C., Mason R.A., Morlock E.V., Schned A.R., Kelsey K.T., Marsit C.J., Moore J.H., Karagas M.R.

Hum. Genet. 125:527-539(2009) · Mapped (5)

Smoking modifies the relationship between XRCC1 haplotypes and HPV16-negative head and neck squamous cell carcinoma.

Applebaum K.M., McClean M.D., Nelson H.H., Marsit C.J., Christensen B.C., Kelsey K.T.

Int. J. Cancer 124:2690-2696(2009) · Mapped (5)

Base excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African-Americans.

Chang J.S., Wrensch M.R., Hansen H.M., Sison J.D., Aldrich M.C., Quesenberry C.P. Jr., Seldin M.F., Kelsey K.T., Wiencke J.K.

Carcinogenesis 30:78-87(2009) · Mapped (41)

Hypermethylation of E-cadherin is an independent predictor of improved survival in head and neck squamous cell carcinoma.

Marsit C.J., Posner M.R., McClean M.D., Kelsey K.T.

Cancer 113:1566-1571(2008) · Mapped (6)

Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans.

Chang J.S., Wrensch M.R., Hansen H.M., Sison J.D., Aldrich M.C., Quesenberry C.P. Jr., Seldin M.F., Kelsey K.T., Kittles R.A., Silva G. et al.

Int. J. Cancer 123:2095-2104(2008) · Mapped (41)

Detecting pathway-based gene-gene and gene-environment interactions in pancreatic cancer.

Duell E.J., Bracci P.M., Moore J.H., Burk R.D., Kelsey K.T., Holly E.A.

Cancer Epidemiol. Biomarkers Prev. 17:1470-1479(2008) · Mapped (38)

A genotype-phenotype examination of cyclin D1 on risk and outcome of squamous cell carcinoma of the head and neck.

Marsit C.J., Black C.C., Posner M.R., Kelsey K.T.

Clin. Cancer Res. 14:2371-2377(2008) · Mapped (5)

DNA repair polymorphisms modify bladder cancer risk: a multi-factor analytic strategy.

Andrew A.S., Karagas M.R., Nelson H.H., Guarrera S., Polidoro S., Gamberini S., Sacerdote C., Moore J.H., Kelsey K.T., Demidenko E. et al.

Hum. Hered. 65:105-118(2008) · Mapped (13)

DNA repair polymorphisms XRCC1 and MGMT and risk of adult gliomas.

Felini M.J., Olshan A.F., Schroeder J.C., North K.E., Carozza S.E., Kelsey K.T., Liu M., Rice T., Wiencke J.K., Wrensch M.R.

Neuroepidemiology 29:55-58(2007) · Mapped (5)

to top of page·

Page of 3 | Next »